Skip to content

BOTALYS

Active
Public limited companyfounded 201115 yrs activeAvenue des Artisans(GHI) 8, 7822 Ath, BelgiumKBO/BCE: BE 0834.134.177
Summary

The annual accounts of BOTALYS for fiscal year 2025 show a net loss of 68% of the equity at the start of that year. The 2025 annual accounts show equity of €4.90M and a net result of €-2.86M. Equity is growing by ~23% per year across the filed fiscal years. Its solvency ranks better than 62% of 190 sector peers (fiscal year 2025). The company has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2025
59 / 100
Fair
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. A net loss of at least half of total assets or of the equity at the start of the financial year caps the score. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability0=
Solvency91▲+24
Growth52=
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €280k at 30 days only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity ample (current ratio 1.95 against 4.42 in 2024; short-term debt: 14.9% and cash: 5% of total assets), and 33.6% of the assets are financed with debt.
Credit check for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 15 years 0 20 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
66.4%
Return on assets
-38.8%
Age of the figures
9 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
31 d early
2024
33 d late
2023
34 d early
2022
67 d early
2021
23 d early
2020
19 d late
2019
21 d late
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€-2.86M▼ 11.1%
2024 · €-2.58M
2018: €-697k 2019: €-738k 2020: €-1.61M 2021: €-2.45M 2022: €-2.62M 2023: €-3.14M 2024: €-2.58M
2018 → 2025
Working capital
€1.05M▼ 71.3%
2024 · €3.67M
2018: €403k 2019: €1.25M 2020: €1.48M 2021: €1.36M 2022: €1.93M 2023: €3.79M 2024: €3.67M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€2.19M-€4.39M▲ 100%€6.78M▲ 54.6%€4.20M▼ 38.1%€4.90M▲ 16.8%
Operating result€-2.47M-€-2.58M▼ 4.6%€-2.86M▼ 10.7%€-3.02M▼ 5.6%€-2.73M▲ 9.5%
Net result€-2.45M-€-2.62M▼ 7.0%€-3.14M▼ 19.7%€-2.58M▲ 18.0%€-2.86M▼ 11.1%
Result per fiscal year
Operating resultNet result
€-4.00M€-3.00M€-2.00M€-1.00M€0Operating result 2021: €-2.47M€-2.47MNet result 2021: €-2.45M€-2.45MOperating result 2022: €-2.58M€-2.58MNet result 2022: €-2.62M€-2.62MOperating result 2023: €-2.86M€-2.86MNet result 2023: €-3.14M€-3.14MOperating result 2024: €-3.02M€-3.02MNet result 2024: €-2.58M€-2.58MOperating result 2025: €-2.73M€-2.73MNet result 2025: €-2.86M€-2.86M20212022202320242025€-4M€-3M€-2M€-1M€0Operating result 2023: €-2.86M€-2.9MNet result 2023: €-3.14M€-3.1MOperating result 2024: €-3.02M€-3MNet result 2024: €-2.58M€-2.6MOperating result 2025: €-2.73M€-2.7MNet result 2025: €-2.86M€-2.9M202320242025
The operating result stays negative: a loss of €2.73M in 2025 against €3.02M in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €7.19M
Fixed assets €5.04M ▼ 1.5%
Current assets €2.15M ▼ 54.6%
Equity and liabilities €7.38M
Equity €4.90M ▲ 16.8%
Debt €2.48M ▼ 57.7%
Debt's share of the balance-sheet total falls from 58.3% to 33.6%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€-1.32M
2024 · €-1.81M
Cash flow
€-1.45M
2024 · €-1.37M
Current ratio
1.95
2024 · 4.42
Quick ratio
1.58
2024 · 3.87
Debt to equity
0.51
2024 · 1.40
ROE
-58.4%
2024 · -61.4%
ROA
-38.8%
2024 · -25.6%
Interest coverage
-4.21
2024 · -11.96
Debt ≤ 1 year
€1.10M
2024 · €1.07M
Debt > 1 year
€1.35M
2024 · €4.75M
Income taxes
€-108
2024 · €88
Staff costs
€1.34M
2024 · €1.78M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 63 lines
Balance sheet Code20242025
Assets
Total assets20/58€10.06M€7.38M
Formation expenses20€202k€189k
Fixed assets21/28€5.12M€5.04M
Intangible fixed assets21€1.92M€2.28M
Tangible fixed assets22/27€3.04M€2.32M
Land and buildings22€830k€708k
Plant, machinery and equipment23€1.90M€1.36M
Furniture and vehicles24€53k€38k
Leasing and similar rights25€144k€106k
Assets under construction and advance payments27€110k€110k=
Financial fixed assets28€168k€441k
Current assets29/58€4.74M€2.15M
Stocks and contracts in progress3€587k€413k
Stocks30/36€587k€413k
Amounts receivable within one year40/41€1.49M€1.29M
Trade receivables40€166k€176k
Other amounts receivable41€1.32M€1.11M
Cash at bank and in hand54/58€2.59M€372k
Deferred charges and accrued income490/1€79k€79k
Equity and liabilities
Total equity and liabilities10/49€10.06M€7.38M
Equity10/15€4.20M€4.90M
Contributions10/11€7.94M€6.12M
Capital10€5.99M€4.18M
Issued capital100€5.99M€4.18M
Outside capital11€1.94M€1.94M=
Share premium1100/10€1.94M€1.94M=
Reserves13€294€294=
Non-distributable reserves130/1€294€294=
Legal reserve130€294€294=
Profit (loss) carried forward14€-5.72M€-2.86M
Investment grants15€1.98M€1.64M
Amounts payable17/49€5.86M€2.48M
Amounts payable after more than one year17€4.75M€1.35M
Financial debts170/4€4.75M€1.35M
Amounts payable within one year42/48€1.07M€1.10M
Current portion of amounts payable after more than one year42€501k€160k
Trade debts44€376k€657k
Suppliers440/4€376k€657k
Taxes, remuneration and social security45€196k€138k
Taxes450/3€0€16k
Remuneration and social security454/9€196k€122k
Other amounts payable47/48-€146k
Accrued charges and deferred income492/3€42k€30k
Income statement Code20242025
Non-recurring operating income76A€5k€5k
Remuneration, social security and pensions62€1.78M€1.34M
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1.21M€1.41M
Other operating charges640/8€38k€42k
Non-recurring operating charges66A€26k€0
Gross operating margin9900€32k€55k
Operating profit (loss)9901€-3.02M€-2.73M
Financial income75/76B€596k€353k
Recurring financial income75€596k€353k
Financial charges65/66B€151k€482k
Recurring financial charges65€151k€314k
Non-recurring financial charges66B-€168k
Profit (loss) for the period before taxes9903€-2.58M€-2.86M
Income taxes67/77€88€-108
Profit (loss) for the period9904€-2.58M€-2.86M
Profit (loss) for the period to be appropriated9905€-2.58M€-2.86M
Appropriation of the result
Profit (loss) to be appropriated9906€-5.72M€-8.58M
Profit (loss) brought forward from the previous period14P€-3.14M€-5.72M
Transfer from equity791/2€0€5.72M
Social balance
Average headcount (FTE)908724.016.8

The notes to these accounts (31 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
30-06
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
26-11
State Gazette act Resignation: Stéphane Ducroux (director)
3 facts ▸
  • General meeting, 09-05-2025
  • General meeting, 16-06-2025
  • Director resignation, Stéphane Ducroux (director)
21-11
State Gazette act Capital & shares · Statutes amendment
Capital increase · Contribution in kind · Capital decrease6 facts ▸
  • General meeting, 12-11-2025
  • Capital increase, €2.940.224,16
  • Contribution in kind, SA BOTALYS, 2940224.16
  • Capital decrease, €5.715.386,34
  • Capital, €4.179.541,13
  • Statutes amendment
11-09
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Statutes amendment9 facts ▸
  • General meeting, 27-08-2025
  • Capital increase, €242.124,28
  • Capital increase, €204.457,5
  • Capital increase, €421.874,46
  • Capital increase, €93.395,72
  • Capital, €6.954.703,31
  • Statutes amendment
  • Power of attorney
  • Power of attorney
02-09
NBB filing Annual accounts filed
fiscal year 2024 · full schema · 33 days late
01-09
State Gazette act Reappointments: Aramon Management SRL, Roberto Viton and CDP Partners - De Wulf & C° SRL
Appointments: Paul-Evence Coppée, Boost Ventures SRL and ALIAD · Permanent representatives: Pol-Henry Bonte, Bertrand Barraud and 2 others · Resignation: Aurélie Schwartzmann (director)12 facts ▸
  • General meeting, 16-06-2025
  • Director reappointment, Aramon Management SRL (director)
  • Director reappointment, Roberto Viton (director)
  • Director appointment, Paul-Evence Coppée (director)
  • Director appointment, Boost Ventures SRL (independent director)
  • Permanent representative, Pol-Henry Bonte
  • Director appointment, ALIAD (director)
  • Permanent representative, Bertrand Barraud
  • Director resignation, Aurélie Schwartzmann (director)
  • Auditor reappointment, CDP Partners - De Wulf & C° SRL (statutory auditor)
  • Permanent representative, Vincent De Wulf
  • Permanent representative, Pierre-Antoine Mariage
2024
10-07
State Gazette act Appointments: Stephane Ducroux, Sparaxis SA and 3 others
Resignations: Spring Services SRL, Samanda SA and 2 others · Agm approval13 facts ▸
  • Board meeting, 28-03-2024
  • Director appointment, Stephane Ducroux (director)
  • Director resignation, Spring Services SRL (independent director)
  • Director appointment, Stephane Ducroux (chair)
  • Director resignation, Samanda SA (chair)
  • Director appointment, Sparaxis SA (director)
  • Director resignation, Samanda SA (director)
  • Director appointment, VIVES Partners SRL (director)
  • Director resignation, Sopartec SA (director)
  • Director appointment, Air Liquide Investissements d'Avenir et de Démonstration SA (director)
  • Director resignation, Olivier Boucat (director)
  • Director appointment, Spring Services SRL (observateur du conseil)
  • +1 further facts in this act
27-06
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial Weakest financial yearnet €-3.14M
Net result drops to €-3.14M, the lowest in the series; recovery starts the following year.
31-12
Financial Equity above €5MEq €6.78M ▲54.6%
Equity rises from €4.39M to €6.78M.
30-05
State Gazette act Capital & shares
Capital decrease · Capital · Capital increase12 facts ▸
  • General meeting, 22-05-2023
  • Capital decrease, €8.662.515,59
  • Capital, €5.352.858,77
  • Capital increase, €639.992,58
  • Capital, €5.992.851,35
  • Capital increase
  • Share issue, Droits de Souscription Anti-Dilutifs, 80
  • Share issue, Droits de Souscription d'Indemnisation, 80
  • Share issue, Droits de Souscription SOP 2022, 7534
  • Capital increase
  • Capital increase
  • Capital increase
25-05
NBB filing Annual accounts filed
fiscal year 2022 · full schema
Show earlier events
17-05
State Gazette act Resignation: EuraAudit de Ghellinck SCRL (statutory auditor)
Appointment: CDP DE WULF & C° SRL (statutory auditor) · Permanent representative: Vincent De Wulf4 facts ▸
  • General meeting, 12-12-2022
  • Director resignation, EuraAudit de Ghellinck SCRL (statutory auditor)
  • Director appointment, CDP DE WULF & C° SRL (statutory auditor)
  • Permanent representative, Vincent De Wulf
2022
17-10
State Gazette act Capital & shares · Statutes amendment · Resignations & appointments
Capital · Capital increase · Share issue17 facts ▸
  • General meeting, 05-09-2022
  • Capital, €14.015.374,36
  • Capital increase, €6.649.814,56
  • Capital increase, €900.000
  • Capital increase
  • Share issue, Droits de Souscription Anti-Dilutifs, 150
  • Share issue, Droits de Souscription d'Indemnisation, 150
  • Share issue, Droits de Souscription SOP 2022, 149421
  • Statutes amendment
  • Bank account, Compte ouvert au nom de la société auprès de la banque BNP Paribas Fortis
  • Share class conversion
  • Subscription rights cancellation, 108
  • +5 further facts in this act
94.5% of this act was read; anything after the cut is not in this list.Read the act at the Belgisch Staatsblad ↗
17-10
State Gazette act Capital & shares
Capital increase · Bank account · Capital4 facts ▸
  • Capital increase, €247.200
  • Bank account, BNP Paribas Fortis, BE45 0019 3271 4589
  • Capital, €6.465.559,8
  • Statutes amendment
30-09
State Gazette act Reappointments: EURAAUDIT DE GHELLINCK SCRL (statutory auditor) and SOPARTEC SA (director)
Appointment: SPARAXIS SA (director) · Resignation: Jean-Nicolas D'Hondt (director)5 facts ▸
  • General meeting, 29-06-2022
  • Auditor reappointment, EURAAUDIT DE GHELLINCK SCRL
  • Director reappointment, SOPARTEC SA (director)
  • Director appointment, SPARAXIS SA (director)
  • Director resignation, Jean-Nicolas D'Hondt (director)
08-07
NBB filing Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial Equity above €2MEq €2.19M ▲86%
Equity rises from €1.18M to €2.19M.
04-11
State Gazette act Reappointments: AGATOS SRL, BOGAERT Jean-Christophe and 4 others
Registered-office move · Mandate compensation11 facts ▸
  • Board meeting, 25-05-2021
  • Registered-office move, Avenue des Artisans, 8 Bt6, 7822 Ghislenghien
  • General meeting, 17-06-2021
  • Director reappointment, AGATOS SRL (director)
  • Mandate compensation, AGATOS SRL
  • General meeting, 26-06-2020
  • Director reappointment, BOGAERT Jean-Christophe (director)
  • Director reappointment, D'hondt Jean-Nicolas (director)
  • Director reappointment, ARAMON MANAGEMENT (director)
  • Director reappointment, SPRING SERVICES (director)
  • Director reappointment, ACID BASE (director)
19-08
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 19 days late
2020
21-08
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 21 days late
14-01
State Gazette act Capital & shares · Statutes amendment
Capital increase · Bank account · Share issue7 facts ▸
  • General meeting, 20-12-2019
  • Capital increase, €5.000.400
  • Bank account, Compte ouvert au nom de la société auprès de la banque ING
  • Share issue, Warrants Anti-dilution 2019
  • Capital, €6.218.359,8
  • Statutes amendment
  • Power of attorney, BOTALYS
2019
31-12
Financial Equity above €2MEq €2.84M ▲139%
Equity rises from €1.19M to €2.84M.
22-07
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
24-04
State Gazette act Capital & shares · Resignations & appointments
Name change · Capital increase · Share issue10 facts ▸
  • General meeting, 28-03-2019
  • Name change, BOTALYS
  • Capital increase, €140.148,8
  • Share issue, 966
  • Bank account, ING Belgique
  • Share issue, warrants anti-dilution 2019
  • Capital, €1.217.959,8
  • Statutes amendment
  • Capital increase
  • Share structure, 8395
28-01
State Gazette act Appointment: Agatos SPRL (director)
Registered-office move · Power of attorney4 facts ▸
  • Board meeting, 13-12-2018
  • Registered-office move, Quai des Usines 8, B - 7800 Ath
  • Director appointment, Agatos SPRL
  • Power of attorney, Paul-Evence Coppée
11-01
State Gazette act Capital & shares
Capital · Statutes amendment · Share liberation7 facts ▸
  • General meeting, 24-10-2018
  • Capital, €1.077.811
  • Statutes amendment
  • Share liberation, 91,10%
  • Bank certificate, 24-10-2018
  • Share liberation deadline, dans le mois des présentes
  • Bank account, Ing Belgique, BE96 3631 8094 0305
2018
19-12
State Gazette act Resignations: COPPEE Paul-Evence René (director and daily management delegate) and André Vandemeulebroecke (permanent representative)
Appointments: AGATOS, ARAMON MANAGEMENT and 3 others · Permanent representatives: COPPEE Paul-Evence René and MARIAGE Pierre-Antoine · Share transfer23 facts ▸
  • General meeting, 24-10-2018
  • Share transfer, HOCCINVEST FONDS SPIN-OFF/SPIN-OUT
  • Statutes amendment
  • Statutes amendment
  • Capital increase, €181.932,3
  • Bank account, Ing Belgique
  • Capital, €1.077.811
  • Share issue, warrants anti-dilution 2018
  • Director resignation, COPPEE Paul-Evence René (director and daily management delegate)
  • Director appointment, AGATOS (director)
  • Permanent representative, COPPEE Paul-Evence René
  • Director appointment, ARAMON MANAGEMENT (director)
  • +11 further facts in this act
01-07
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
30-01
State Gazette act Capital & shares
Capital increase · Bank account · Capital5 facts ▸
  • General meeting, 21-12-2017
  • Capital increase, €447.378,75
  • Bank account, 20-12-2017
  • Capital, €895.878,75
  • Statutes amendment
2017
01-08
NBB filing Annual accounts filed
fiscal year 2016 · full schema · 1 day late
21-06
State Gazette act Capital & shares
Share issue · Capital increase · Statutes amendment8 facts ▸
  • General meeting, 17-05-2017
  • Share issue, 400 Warrants SOP A et 267 Warrants SOP E, sous réserve d'inscription
  • Capital increase
  • Statutes amendment
  • Power of attorney, Deux administrateurs agissant conjointement
  • Share conversion, 48 actions de catégorie B
  • Waiver, Renonciation à titre individuel et de manière expresse et irrévocable au droit de souscription préférentielle et à son délai d'exercice, réservant tout ou parti…
  • Warrant allocation, 267 Warrants SOP E par décision du conseil d'administration conformément au rapport annexé
2016
29-07
State Gazette act Resignation: Etienne MARIAGE (director)
Appointments: SOPARTEC (director) and SCRL EuraAudit de Ghellinck Réviseurs d'Entreprises (statutory auditor) · Permanent representative: André Vandemeulebroecke · Capital increase11 facts ▸
  • General meeting, 24-06-2016
  • Capital increase, €103.500
  • Share issue, 1425
  • Share issue, warrants anti-dilution, 21
  • Capital, €448.500
  • Director resignation, Etienne MARIAGE (director)
  • Director appointment, SOPARTEC (director)
  • Permanent representative, André Vandemeulebroecke
  • Auditor appointment, SCRL EuraAudit de Ghellinck Réviseurs d'Entreprises
  • Share category creation
  • Capital increase
06-07
State Gazette act Resignation: Pierre-Antoine Mariage (managing director)
Appointment: Aramon Management (manager) · Permanent representative: Pierre-Antoine Mariage · Director discharge5 facts ▸
  • General meeting, 27-05-2016
  • Director resignation, Pierre-Antoine Mariage (managing director)
  • Director discharge, Pierre-Antoine Mariage
  • Director appointment, Aramon Management (manager)
  • Permanent representative, Pierre-Antoine Mariage
2014
23-10
State Gazette act Appointments: Jean-Christophe Bogaert (director) and Jean-Nicolas D'Hondt (director)
5 facts ▸
  • General meeting, 02-10-2014
  • Director appointment, Jean-Christophe Bogaert (director)
  • Director appointment, Jean-Nicolas D'Hondt (director)
  • Board composition, Pierre-Antoine Mariage (director)
  • Board composition, Paul-Evence Coppée (director)
13-08
State Gazette act Registered office · Capital & shares · Statutes amendment · Resignations & appointments
Name change · Registered-office move · Capital increase18 facts ▸
  • General meeting, 31-07-2014
  • Name change, GREEN2CHEM S.A.
  • Registered-office move, 7822 Ath (Ghislenghien), rue des Foudriers, n°1
  • Capital increase, €275.000
  • Share issue, 80, A
  • Share issue, 320, B
  • Share issue, 80, B
  • Share issue, 80, B
  • Share issue, 80, B
  • Share issue, 80, B
  • Share issue, 80, B
  • Share issue, 750, C
  • +6 further facts in this act
29-07
State Gazette act Resignation: Laurent Capucine (director)
Appointment: Paul-Evence Coppée (director) · Director discharge · Mandate compensation8 facts ▸
  • General meeting, 01-11-2013
  • Director resignation, Laurent Capucine (director)
  • Director discharge, Laurent Capucine
  • Director appointment, Paul-Evence Coppée (director)
  • Mandate compensation, Paul-Evence Coppée
  • Board meeting, 01-11-2013
  • Director appointment, Paul-Evence Coppée (managing director)
  • Director appointment, Paul-Evence Coppée (day-to-day manager)
2011
11-03
State Gazette act Incorporation
Appointments: MARIAGE Pierre-Antoine, Brigitte, Ignace, LAURENT Capucine and MARIAGE Etienne Léon, Marie, Luc · Founding capital · Bank account20 facts ▸
  • Incorporation, 18-02-2011
  • Founding capital, €70.000
  • Bank account, 363-0830777-12
  • General meeting, 18-02-2011
  • Director appointment, MARIAGE Pierre-Antoine, Brigitte, Ignace (director)
  • Director appointment, LAURENT Capucine (director)
  • Director appointment, MARIAGE Etienne Léon, Marie, Luc (director)
  • Mandate compensation, MARIAGE Pierre-Antoine, Brigitte, Ignace
  • Mandate compensation, LAURENT Capucine
  • Mandate compensation, MARIAGE Etienne Léon, Marie, Luc
  • Board meeting, 18-02-2011
  • Director appointment, MARIAGE Pierre-Antoine, Brigitte, Ignace (managing director)
  • +8 further facts in this act
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
19 directors, last change in 2025
Aramon Management SRL
Director · since 16-06-2025 · Legal entity · perm. rep.: Pierre-Antoine Mariage
Current
Boost Ventures SRL
Independent director · since 16-06-2025 · Legal entity · perm. rep.: Pol-Henry Bonte
Current
Paul-Evence Coppée
Director · since 16-06-2025
Current
Roberto Viton
Director · since 16-06-2025
Current
ALIAD
Director · since 10-02-2025 · Legal entity · perm. rep.: Bertrand Barraud
Current
Air Liquide Investissements d'Avenir et de Démonstration SA
Director · since 28-03-2024 · Legal entity
Current
13 other directors
Spring Services SRL
Observateur du conseil · since 28-03-2024 · Legal entity
Current
VIVES Partners SRL
Director · since 28-03-2024 · Legal entity
Current
Sparaxis SA
Director · since 29-06-2022 · Legal entity
Current
AGATOS SRL
Director · since 17-06-2021 · Legal entity
Current
ACID BASE
Director · since 26-06-2020 · Legal entity
Current
ARAMON MANAGEMENT
Director · since 26-06-2020 · Legal entity
Current
SPRING SERVICES
Director · since 26-06-2020 · Legal entity
Current
BOGAERT Jean-Christophe
Director · since 02-10-2014
Current
Agatos SPRL
Director · since 16-01-2019 · Legal entity
Not recently confirmed
AGATOS
Director · since 29-05-2018 · Private limited company (pre-2019) · perm. rep.: COPPEE Paul-Evence René
Not recently confirmed
ARAMON MANAGEMENT
Director · since 27-05-2016 · Private limited company (pre-2019) · perm. rep.: Pierre-Antoine Mariage
Not recently confirmed
BOGAERT Jean-Christophe Robert
Director · since 01-01-2017
Not recently confirmed
SOPARTEC
Director · since 24-06-2016 · Public limited company · perm. rep.: André Vandemeulebroecke
Not recently confirmed
16-06-2025 Aramon Management SRL: Mandate renewed as Director
16-06-2025 Boost Ventures SRL: Appointed as Independent director
16-06-2025 Paul-Evence Coppée: Appointed as Director
16-06-2025 Roberto Viton: Mandate renewed as Director
16-06-2025 Aurélie Schwartzmann: Resigned as Director
Full history in the Timeline (48 changes) →
Not every act has been read: a resignation may be missing here
1 act was read only in part. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Ath · 1 establishment unit since 2020
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Avenue des Artisans(GHI) 87822 Ath
Ground area
4.3 ha
Building footprint
2.0 ha
Volume, LiDAR
164,532 m³
Parcel 51024A0480/00E000, Wallonia · tallest building 10.3 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
BOTALYS
Avenue des Artisans(GHI) 8, 7822 AthManufacture of food products
since 20202.300.632.340
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
51024A0480/00E000 Wallonia 4.3 ha 1 · 2.0 ha 10.3 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Statutory auditor

1 auditor
CDP Partners - De Wulf & C° srlCurrent
Statutory auditor · represented by Vincent De Wulf
16-06-2025 → present
Show 3 earlier auditors
CDP De Wulf & C° srl
Statutory auditor · represented by Vincent De Wulf
succeeded by CDP Partners - De Wulf & C° srl in 2025
12-12-2022 → 16-06-2025
SCRL EuraAudit de Ghellinck
Auditor
29-06-2022 → 12-12-2022
SCRL EuraAudit de Ghellinck Réviseurs d'Entreprises
Auditor
succeeded by CDP De Wulf & C° srl in 2022
24-06-2016 → 12-12-2022

Articles of association

Purpose
La société a pour objet à titre principal ou accessoire, tant pour son compte propre que pour compte de tiers - la recherche et le développement au sens le plus large; - le…
Full purpose

La société a pour objet à titre principal ou accessoire, tant pour son compte propre que pour compte de tiers - la recherche et le développement au sens le plus large; - le développement de produits, de services et de consultance dans le domaine de la production, de la modification, appliqués notamment à la recherche, au développement et à la production de matières et d'énergie renouvelables: la fabrication, la transformation, la commercialisation, l'importation et l'exportation par tous canaux de distribution, de matières premières, de produits finis, de produits biologiques, chimiques, de concentrés de vitamines, de minéraux, de plantes et d'extraits de plantes, de protéines, d'additifs, ainsi que la prestation de services dans tous ces domaines au sens le plus large. Au cas où la prestation de certains actes serait soumise à des conditions préalables d'accès à la profession, la société subordonnera son action, en ce qui concerne la prestation de ces services, à la réalisation de ces conditions; - immobilier pour compte propre, gestion de tout patrimoine immobilier; - toutes opérations immobilières, la promotion, l'achat, la vente, la location d'immeubles meublés ou non, la négociation, la représentation, la vente de tous produits se rapportant directement ou indirectement à l'immobilier; - la société a également pour objet l'exploitation de surfaces commerciales, la prestation de tous services de gestion et de direction dans d'autres sociétés ou entreprises aussi bien belges qu'étrangères; la prestation de services administratifs, techniques, informatiques, juridiques et de représentation pour compte de tiers vis-à-vis de toutes instances et pouvoirs publics; - la société peut également exercer les fonctions d'administrateur, de gérant ou de liquidateur dans d'autres sociétés; la société peut aussi prendre des participations directes ou indirectes dans toute société ou entreprise industrielle, financière, mobilière ou immobilière belge ou étrangère, le contrôle de leur gestion ou la participation à celle-ci par la prise de tout mandat au sein des dites sociétés ou entreprises, l'achat, l'administration, la vente de toutes valeurs mobilières et immobilières de tous droits sociaux et d'une manière plus générale toutes les opérations de gestion du portefeuille ainsi constitué; la société peut effectuer toutes opérations commerciales, industrielles, financières, mobilières ou immobilières se rattachant directement ou indirectement à son objet ou pouvant en faciliter la réalisation. Elle peut s'intéresser, par toutes voies, dans toutes affaires, entreprises ou sociétés ayant un objet identique, analogue ou connexe, ou qui sont de nature à favoriser le développement de son entreprise, à lui procurer des matières premières ou à faciliter l'écoulement de ses produits; - la société peut faire, toutes opérations commerciales, industrielles, financières, civiles, mobilières et immobilières se rapportant directement ou indirectement en tout ou en partie à l'objet social ou qui seraient de nature à en faciliter la réalisation, en Belgique ou à l'étranger. De même, elle pourra s'intéresser par voie d'apports, de fusion, de scission, de souscription ou autrement, dans toutes entreprises et sociétés ayant un objet similaire ou connexe, ou de nature à favoriser le développement de son entreprise.

Structure & network

Connections & network

16 connected companies
Paul-Evence Coppée, Shared director, links 5 companies PCPaul-EvenceCoppéeCOMPAGNIE HET ZOUTE - RESERVE, via Paul-Evence Coppée CHCOMPAGNIE HETZOUTE - RESERVEGALACTIC, via Paul-Evence Coppée GGALACTICWulfsdonck Investment, via Paul-Evence Coppée WIWulfsdonckInvestmentISERA & SCALDIS SUGAR, via Paul-Evence Coppée ISISERA &SCALDIS SUGARSociété Financière des Sucres, via Paul-Evence Coppée SFSociétéFinancière…BRUSSELS LIFE SCIENCE INCUBATOR, Shared corporate director BLBRUSSELS LIFESCIENCE…CISSOID, Shared corporate director CCISSOIDintoPIX, Shared corporate director IintoPIXiTeos Belgium, Shared corporate director IBiTeos Belgiumn-Side, Shared corporate director Nn-SideNOVADIP BIOSCIENCES, Shared corporate director NBNOVADIPBIOSCIENCESREACFIN, Shared corporate director RREACFINSiPulse, Shared corporate director SSiPulseBOTALYS BOTALYS0834.134.177
Shared directors
Linked via shared directors
Show 12 more companies with a shared director
BRUSSELS LIFE SCIENCE INCUBATOR
Shared corporate director
CISSOID
Shared corporate director
intoPIX
Shared corporate director
iTeos Belgium
Shared corporate director
n-Side
Shared corporate director
NOVADIP BIOSCIENCES
Shared corporate director
REACFIN
Shared corporate director
SiPulse
Shared corporate director
Sunrise
Shared corporate director
The Akkermansia Company
Shared corporate director
VIVES II - Louvain Technology Fund
Shared corporate director

Capital and shareholders

Shareholders according to the acts
After 5 capital increases act of 17-10-2022 ↗
  • COPPEE Paul-Evence 200 shares · 80,000 EUR
  • ARAMON MANAGEMENT 200 shares · 80,000 EUR
  • CUIGNET Giannino 69 shares · 27,600 EUR
  • CLOET Annie 69 shares · 27,600 EUR
  • DENIS Robin 80 shares · 32,000 EUR
  • SOCIETE REGIONALE D'INVESTISSEMENT DE WALLONIE
  • HOCCINVEST FONDS SPIN-OFF/SPIN-OUT
  • AIR LIQUIDE INVESTISSEMENTS D'AVENIR ET DE DEMONSTRATION
  • THE YIELD LAB EUROPE FUND 1 LIMITED PARTNERSHIP
  • de SPOELBERCH Rodolphe Roger Baudouin
  • EQC AGRIFUND LTD
  • BH PARTICIPATIONS LTD
  • CORSINI Clemente
  • VIVES II - LOUVAIN TECHNOLOGY FUND
  • MYRIALIFE
  • SOCIÉTÉ DE DÉVELOPPEMENT ET DE PARTICIPATION DE LA WALLONIE PICARDIE
  • ARCARIUS MANAGEMENT
After the capital increase act of 19-12-2018 ↗
Share transfer act of 19-12-2018 ↗
  • from HOCCINVEST FONDS SPIN-OFF/SPIN-OUT 925 shares

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 21-11-2025 Capital increase of 2,940,224.16 EUR · to 9,894,927.47 EUR · 422,446 new shares · in kind
  2. 21-11-2025 Capital reduction of 5,715,386.34 EUR · to 4,179,541.13 EUR · to absorb losses
  3. 11-09-2025 Capital increase of 242,124.28 EUR · to 6,234,975.63 EUR · 51,958 new shares · in cash
  4. 11-09-2025 Capital increase of 204,457.50 EUR · to 6,439,433.13 EUR · 43,875 new shares · in kind
  5. 11-09-2025 Capital increase of 421,874.46 EUR · to 6,861,307.59 EUR · 90,531 new shares · in kind
  6. 11-09-2025 Capital increase of 93,395.72 EUR · to 6,954,703.31 EUR · 20,042 new shares · in kind
  7. 30-05-2023 Capital reduction of 8,662,515.59 EUR · to 5,352,858.77 EUR · to absorb losses
  8. 30-05-2023 Capital increase of 639,992.58 EUR · to 5,992,851.35 EUR · 47,442 new shares · in cash
Show 11 older capital entries
  1. 17-10-2022 Capital increase of 247,200 EUR · to 6,465,559.80 EUR
  2. 17-10-2022 Capital increase of 6,649,814.56 EUR · to 13,115,374.36 EUR · 492,944 new shares
  3. 17-10-2022 Capital increase of 900,000 EUR · to 14,015,374.36 EUR · 74,129 new shares
  4. 14-01-2020 Capital increase of 5,000,400 EUR · to 6,218,359.80 EUR · 4,167 new shares
  5. 24-04-2019 Capital increase of 140,148.80 EUR · to 1,217,959.80 EUR · 966 new shares
  6. 11-01-2019 Capital stated in the act · 1,077,811 EUR · 7,429 shares
  7. 19-12-2018 Capital increase of 181,932.30 EUR · to 1,077,811 EUR · 1,254 new shares
  8. 30-01-2018 Capital increase of 447,378.75 EUR · to 895,878.75 EUR · “majoration du pair comptable des actions existantes”
  9. 29-07-2016 Capital increase of 103,500 EUR · to 448,500 EUR · 1,425 new shares
  10. 13-08-2014 Capital increase of 275,000 EUR · to 345,000 EUR · 1,550 new shares
  11. 11-03-2011 Incorporation · 70,000 EUR · 100 shares

Public money · subsidies and aid

European research

2 projects · 2 as coordinator · 2,255,000 EUR EU contribution
Programmes
Horizon 2020
2 entries · 2,255,000 EUR
Projects
A novel cost-efficient hydroponic technology to grow high value plant roots for nutraceuticals, pharmaceuticals & cosmetics
Horizon 2020 · coordinator · 01-03-2019 to 31-05-2021 · 2,205,000 EUR · Rhizomia
A novel cost-efficient bioreactor to accelerate growth of valuable plant roots for nutraceuticals, pharmaceuticals cosmetics
Horizon 2020 · coordinator · 01-02-2017 to 31-05-2017 · 50,000 EUR · Rhizomia

Recognitions · licences · registrations

Food safety, FASFC

1 site
Ath2.300.632.340
2 permissions
Toelating · Fabrikant andere producten plantaardige · since 05-04-2022
Boerderij - akkerbouw · since 01-01-2020

Similar companies · same sector, comparable size

Of 761 companies in sector 72101 we hold annual accounts for 481. 203 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded01-03-2011
Fiscal year end31-12
Activities, NACEBEL 2025
01280Crop and animal production, hunting and related service activities
72101Research and development on biotechnology
72109Other research and development on natural sciences
Sources
Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.